glutathione bromopyruvic acid reaction

glutathione bromopyruvic acid reaction Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment Phase II - Glutathione Conjugation

Name: glutathione bromopyruvic acid reaction Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment Phase II - Glutathione Conjugation
Brand: clintoncounty708.com
SKU: 18135353944
Price: 20.07 USD
Availability: InStock
Rating: 4.6489 (14 reviews)

Phase II Glutathione Conjugation Metabolism of Herbicides or Xenobiotics in Plants passel Anticancer agent 3 bromopyruvic acid forms a conjugate with glutathione ScienceDirect The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect Glutathione System from Cyanobacteria to Higher Eukaryotes Encyclopedia MDPI

SKU: 18135353944 · From clintoncounty708.com

4.6

USD20.07 USD54.07

Pay in 4 interest-free payments of $5.02 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

Description

Ernster, L., Danielson, L

By accurately identifying high-risk populations through patient stratification tools, this approach reduces the number needed to treat (NNT), minimizes patients' exposure to unnecessary pharmacological toxicity, and effectively lowers the population-level incidence of cardiovascular diseases, while simultaneously optimizing the allocation of healthcare resources (206)